Techniques: Combining genetic and small molecule screens to identify therapeutic targets for rare cancers

Assays and screens

TECHNOLOGY: Cellular assays

A protocol that combines the results of gene editing, RNAi and small molecule screens in patient-derived cancer cell lines could help identify therapeutic targets for rare cancers lacking known

Read the full 331 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE